Blog

RSS Feed
Posted by Michael Wonder on 11 Oct 2021

Tegsedi receives innovative drug category pricing in Brazil

11 October 2021 - PTC Therapeutics today announced that Tegsedi (inotersen) has successfully received Category 1 classification from Câmara de ...

Read more →